References
- Baek M, Chung H-E, Yu J, et al. (2012). Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomed 7:3081–97
- Bergen JM, von Recum HA, Goodman TT, et al. (2006). Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci 6:506–16
- Cho WS, Cho M, Jeong J, et al. (2009). Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24
- Daniel MC, Astruc D. (2004). Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104:293–346
- Daniel MC, Ruiz J, Nlate S, et al. (2001). Gold nanoparticles containing redox-active supramolecular dendrons that recognize H2PO4. Chem Commun (Camb) 19:2000–1
- Donovan MD, Flynn GL, Amidon GL. (1990). Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption. Pharm Res 7:863–8
- Frens G. (1972). Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 241:20–2
- Geng F, Xing JZ, Chen J, et al. (2014). Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer. J Biomed Nanotechnol 10:1205–16
- Giljohann DA, Seferos DS, Daniel WL, et al. (2010). Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 49:3280–94
- Hillyer JF, Albrecht RM. (2001). Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–36
- Hinkley GK, Carpinone P, Munson JW, et al. (2015). Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter? Part Fibre Toxicol 12:1–12
- Kim MK, Lee JA, Jo MR, Choi SJ. (2016). Bioavailability of silica, titanium dioxide, and zinc oxide nanoparticles in rats. J Nanosci Nanotechnol 16:6580–6
- Larson-Smith K, Pozzo DC. (2012). Competitive adsorption of thiolated poly(ethylene glycol) and alkane-thiols on gold nanoparticles and its effect on cluster formation. Langmuir 28:13157–65
- Lee Y, Kim P, Yoon J, et al. (2013). Serum kinetics, distribution and excretion of silver in rabbits following 28 days after a single intravenous injection of silver nanoparticles. Nanotoxicology 7:1120–30
- Lin Z, Monteiro-Riviere NA, Riviere JE. (2015). Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:189–217
- Lipka J, Semmler-Behnke M, Sperling RA, et al. (2010). Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31:6574–81
- Niidome T, Yamagata M, Okamoto Y, et al. (2006). PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–7
- Park k, Park EJ, Chun IK, et al. (2011). Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34:153–8
- Salata OV. (2004). Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:1–6
- Schleh C, Semmler-Behnke M, Lipka J, et al. (2012). Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 6:36–46
- Smith CA, Simpson CA, Kim G, et al. (2013). Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticles. ACS Nano 7:3991–6
- Zhang Y-N, Poon W, Tavares AJ, et al. (2016). Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination. J Control Release 240:332–48